Summary
The Antoni van Leeuwenhoek is offering a PhD position focused on early response prediction and recurrence detection in patients with resectable melanoma using liquid biomarkers, specifically circulating tumor DNA (ctDNA). This role is essential for developing personalized surveillance strategies to enhance melanoma treatment outcomes.
PhD Position in Molecular Oncology, Netherlands Cancer Institute, Amsterdam
Designation
PhD Candidate in Molecular Oncology
Table
| Feature | Details |
|---|---|
| Research Area | Molecular Oncology, Liquid Biomarkers |
| Location | Netherlands Cancer Institute, Amsterdam |
| Salary | €3,738 – €4,539 per month |
| Contract Duration | 4 years |
| Working Hours | 36 hours per week |
Eligibility/Qualification
- Master’s degree in Biomedical Sciences, Oncology, Biology, or similar fields.
- Experience in laboratory research.
- Strong understanding of molecular biology and oncology principles.
- Knowledge of ctDNA testing, including ddPCR and NGS.
- Ambition, motivation, and creativity are essential.
- Proficiency in English.
Description
The project aims to optimize surveillance for stage III melanoma patients post-surgery by analyzing ctDNA dynamics. The successful candidate will collaborate with a multidisciplinary team and be responsible for various tasks, including:
- Optimization of melanoma surveillance assays.
- Conducting molecular analysis of ctDNA data.
- Development of multimodal classifiers.
- Designing research studies and manuscript preparation.
How to Apply
Interested candidates must apply through the application form by attaching a motivation letter, CV, and contact details of two references. Applications sent via email will not be accepted.
Last Date to Apply
22 March 2026
For further inquiries about the position:
- Contact: Paul van der Leest, Postdoctoral Fellow
- Email: p.vd.leest@nki.nl
- Phone: 020 512 9109
For questions about the application procedure:
- Contact: Daphne Heemskerk, Recruitment
- Email: d.heemskerk@nki.nl
